Sphingidae (Lepidoptera: Bombycoidea) assemblage inthe State Ecological Station of Wenceslau Guimarães,Bahia, Brazil

The diversity of hawkmoths (Lepidoptera: Sphingidae) is poorly known in the biomes of the Bahia state. However, studies were carried out in other states of the northeastern region with species inventories in the Atlantic Forest, Caatinga and Cerrado. In order to broaden the knowledge on of the richness and diversity of hawkmoths in the Atlantic Forest of the state of Bahia, six monthly sampling sessions were carried out in the State Ecological Station of Wenceslau Guimarães. Hawkmoths were captured using a 250-watt mercury-vapor light trap set against a white cloth panel, for two nights a month, between 6:00 p.m. and 6:00 a.m. A total of 266 specimens were collected, distributed across 17 genera and 41 species. The most abundant and dominant species were Isognathus swainsoniC. Felder, 1862, with a relative abundance of 12.41%, and Xylophanes amadis(Cramer, 1782) andXylophanes anubus(Cramer, 1777), both with 7.9%. Our study represents the second inventory of hawkmoths for the state, totaling 59 species known for the Atlantic Forest of Bahia. Isognathus excelsior(Boisduval, [1875]) and Manduca lucetius(Cramer, 1780) represented new records for the biome. The accumulated number of species indicates the need for further sampling in order to safely reach the curve asymptote.

Efeitos do alisquereno e de mudanças no estilo de vida na atenuação da hipertensão arterial associada à síndrome metabólica / Effects of aliskiren and short-term lifestyle modifications on the decrease of arterial hypertension associated with metabolic syndrome

Apresenta-se paciente com hipertensão arterial não controlada com a terapêutica atual e portador de outros fatores de risco de doença cardiovascular. Serão abordadas as identificação do risco cardiovascular e as medidas medicamentosas e não medicamentosas a serem instituídas para redução do risco futuro. O caso será visto à luz da V Diretrizes Brasileiras de Hipertensão Arterial e das evidências científicas atuais. Finalmente, serão discutidos os resultados obtidos com a substituição do inibidor da enzima de conversão da angiotensina pelo alisquireno.

A case report of a patient with uncontrolled hypertension is presented. The authors describe how to stratify his cardiovascular risk and the treatment goals. Considering the Brazilian Guidelines of Hypertension this case is discussed. Aliskiren, the first approved pharmaceutical drug to manage hypertension by direct renin inhibition is described. Finally the authors compare aliskiren to angiotensin-converting enzyme inhibitor.